Application prospect of oncolytic virus detection of circulating tumor cell in precision medicine of bladder cancer
10.16571/j.cnki.1008-8199.2020.06.017
- VernacularTitle: 溶瘤病毒检测循环肿瘤细胞在膀胱癌精准治疗中的应用展望
- Author:
Shi-lin LI
1
;
Yong TANG
1
Author Information
1. Division of Urology, Wuming Hospital of Guangxi Medical University, Nanning 530199,Guangxi,China
- Publication Type:Journal Article
- Keywords:
bladder cancer;
circulating tumor cell;
oncolytic virus;
precision medicine
- From:
Journal of Medical Postgraduates
2020;33(6):644-650
- CountryChina
- Language:Chinese
-
Abstract:
Morbidity and mortality rates of bladder cancer (BC) are still rising with a poor prognosis. Therefore, better biomarkers are urgently needed to advance the accurate diagnosis and treatment of BC. The limitations of the different detection techniques of circulating tumor cell (CTC) cause that the CTC as biomarkers of point of view of diagnosis and treatment of BC is not yet clear. This review first compares and analyzes the current CTC detection technology methods, and then reviews the five aspects of screening, diagnosis, staging, curative effect monitoring, prognostic evaluation, and personalized treatment of patients with malignant tumors with oncolytic virus and CTC. The application of oncolytic virus detection CTC in BC was evaluated. The results suggest that oncolytic virus with fluorescent protein combined with fluorescence microscopy and flow cytometer are used to detect CTC. This method can be only used to detect live CTCs, instead of dead CTCs. The CTC count is more accurate, efficient with high sensitivity and specificity. It can also perform phenotypic analysis of CTC and single-cell sequencing. It can be used for screening, diagnosis, and guidance of targeted therapy for bladder cancer, assessing efficacy and judging prognosis which has a very broad clinical application prospect for advancing the accurate diagnosis and treatment of BC.
